255 related articles for article (PubMed ID: 20446852)
21. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.
Wong GY; Gavva NR
Brain Res Rev; 2009 Apr; 60(1):267-77. PubMed ID: 19150372
[TBL] [Abstract][Full Text] [Related]
22. Pruritus: an overview of current concepts.
Metz M; Grundmann S; Ständer S
Vet Dermatol; 2011 Apr; 22(2):121-31. PubMed ID: 21251097
[TBL] [Abstract][Full Text] [Related]
23. A randomised trial evaluating the effects of the TRPV1 antagonist SB705498 on pruritus induced by histamine, and cowhage challenge in healthy volunteers.
Gibson RA; Robertson J; Mistry H; McCallum S; Fernando D; Wyres M; Yosipovitch G
PLoS One; 2014; 9(7):e100610. PubMed ID: 25047038
[TBL] [Abstract][Full Text] [Related]
24. Application of an 8% capsaicin patch normalizes epidermal TRPV1 expression but not the decreased intraepidermal nerve fibre density in patients with brachioradial pruritus.
Pereira MP; Lüling H; Dieckhöfer A; Steinke S; Zeidler C; Agelopoulos K; Ständer S
J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1535-1541. PubMed ID: 29427475
[TBL] [Abstract][Full Text] [Related]
25. Capsaicin for neuropathic pain: linking traditional medicine and molecular biology.
Haanpää M; Treede RD
Eur Neurol; 2012; 68(5):264-75. PubMed ID: 23037991
[TBL] [Abstract][Full Text] [Related]
26. Upcoming topical TRPV1 anti-pruritic compounds.
Lee KP; Koshelev MV
Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054935
[TBL] [Abstract][Full Text] [Related]
27. [The TRPV1 channel as a target for the treatment of pain].
Salazar H; Jara-Oseguera A; Rosenbaum T
Rev Neurol; 2009 Apr 1-15; 48(7):357-64. PubMed ID: 19319817
[TBL] [Abstract][Full Text] [Related]
28. Signaling mechanisms of down-regulation of voltage-activated Ca2+ channels by transient receptor potential vanilloid type 1 stimulation with olvanil in primary sensory neurons.
Wu ZZ; Chen SR; Pan HL
Neuroscience; 2006 Aug; 141(1):407-19. PubMed ID: 16678970
[TBL] [Abstract][Full Text] [Related]
29. Ion channels in analgesia research.
Rosenbaum T; Simon SA; Islas LD
Methods Mol Biol; 2010; 617():223-36. PubMed ID: 20336426
[TBL] [Abstract][Full Text] [Related]
30. Receptor changes in brain tissue of rats treated as neonates with capsaicin.
Zavitsanou K; Dalton VS; Wang H; Newson P; Chahl LA
J Chem Neuroanat; 2010 Jul; 39(4):248-55. PubMed ID: 20123014
[TBL] [Abstract][Full Text] [Related]
31. Ask the doctor. I have pain from osteoarthritis in both knees. I'm curious about the cream made from a substance in hot peppers. How does it relieve pain?
Robb-Nicholson C
Harv Womens Health Watch; 2011 Oct; 19(2):8. PubMed ID: 22132441
[No Abstract] [Full Text] [Related]
32. Role of TRPV1 receptors in descending modulation of pain.
Palazzo E; Rossi F; Maione S
Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S79-83. PubMed ID: 18325659
[TBL] [Abstract][Full Text] [Related]
33. Adlea (ALGRX-4975), an injectable capsaicin (TRPV1 receptor agonist) formulation for longlasting pain relief.
Remadevi R; Szallisi A
IDrugs; 2008 Feb; 11(2):120-32. PubMed ID: 18240098
[TBL] [Abstract][Full Text] [Related]
34. Possible role for TRPV1 in neomycin-induced inhibition of visceral hypersensitivity in rat.
van den Wijngaard RM; Welting O; Bulmer DC; Wouters MM; Lee K; de Jonge WJ; Boeckxstaens GE
Neurogastroenterol Motil; 2009 Aug; 21(8):863-e60. PubMed ID: 19298229
[TBL] [Abstract][Full Text] [Related]
35. Research progress of capsaicin responses to various pharmacological challenges.
Patowary P; Pathak MP; Zaman K; Raju PS; Chattopadhyay P
Biomed Pharmacother; 2017 Dec; 96():1501-1512. PubMed ID: 29198921
[TBL] [Abstract][Full Text] [Related]
36. Enhanced itch elicited by capsaicin in a chronic itch model.
Yu G; Yang N; Li F; Chen M; Guo CJ; Wang C; Hu D; Yang Y; Zhu C; Wang Z; Shi H; Gegen T; Tang M; He Q; Liu Q; Tang Z
Mol Pain; 2016; 12():. PubMed ID: 27118771
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of TRPV1 channels by a naturally occurring omega-9 fatty acid reduces pain and itch.
Morales-Lázaro SL; Llorente I; Sierra-Ramírez F; López-Romero AE; Ortíz-Rentería M; Serrano-Flores B; Simon SA; Islas LD; Rosenbaum T
Nat Commun; 2016 Oct; 7():13092. PubMed ID: 27721373
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms involved in potentiation of transient receptor potential vanilloid 1 responses by ethanol.
Vetter I; Wyse BD; Roberts-Thomson SJ; Monteith GR; Cabot PJ
Eur J Pain; 2008 May; 12(4):441-54. PubMed ID: 17826200
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of cochinchinenin B on capsaicin-activated responses in rat dorsal root ganglion neurons.
Wang ST; Chen S; Guo M; Liu XM
Brain Res; 2008 Mar; 1201():34-40. PubMed ID: 18294619
[TBL] [Abstract][Full Text] [Related]
40. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway.
Gunthorpe MJ; Chizh BA
Drug Discov Today; 2009 Jan; 14(1-2):56-67. PubMed ID: 19063991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
